FCMI
Foresite Capital Management I Portfolio holdings
AUM
$21.4M
This Quarter Return
+17.08%
1 Year Return
-80.48%
3 Year Return
-40.72%
5 Year Return
–
10 Year Return
–
AUM
$102M
AUM Growth
–
Cap. Flow
+$102M
Cap. Flow
% of AUM
100%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
8
New
7
Increased
–
Reduced
–
Closed
–
Top Buys
| 1 |
Karyopharm Therapeutics
KPTI
|
$32.6M |
| 2 |
AMBI
AMBIT BIOSCIENCES CORP COM STK (DE)
AMBI
|
$20M |
| 3 |
KERX
Keryx Biopharmaceuticals Inc
KERX
|
$17M |
| 4 |
Talphera
TLPH
|
$15.6M |
| 5 |
Xencor
XNCR
|
$7.5M |
Top Sells
No sells this quarter
Sector Composition
| 1 | Healthcare | 80.39% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Karyopharm Therapeutics
KPTI
$61.7M
| $32.6M | 31.69% | +1,585,743 | New | +$32.6M |
|
|
AMBI
2
DELISTED
AMBIT BIOSCIENCES CORP COM STK (DE)
AMBI
| $20M | 19.47% | +2,079,569 | New | +$20M |
|
|
KERX
3
DELISTED
Keryx Biopharmaceuticals Inc
KERX
| $17M | 16.5% | +1,312,006 | New | +$17M |
|
|
4
Talphera
TLPH
$11.1M
| $15.6M | 15.15% | +1,379,080 | New | +$15.6M |
|
|
5
Xencor
XNCR
$580M
| $7.5M | 7.28% | +820,000 | New | +$7.5M |
|
6
Novavax
NVAX
$1.21B
| $6.84M | 6.65% | +1,336,200 | New | +$6.84M |
|
|
XLRN
7
DELISTED
Acceleron Pharma Inc.
XLRN
| $2.61M | 2.54% | +66,000 | New | +$2.61M |
|
|
BDSI
8
DELISTED
BioDelivery Sciences International, Inc.
BDSI
| – | – | 0 | – | – |
|